This subproject is one of many research subprojects utilizing theresources provided by a Center grant funded by NIH/NCRR. The subproject andinvestigator (PI) may have received primary funding from another NIH source,and thus could be represented in other CRISP entries. The institution listed isfor the Center, which is not necessarily the institution for the investigator.This proposal tests the central hypothesis that expression of the osteoinhibtory protein ligand, Dkk-1,contributes to the formation of bone lesions in osteosarcoma and some metastatic bone diseases by inhibiting the natural process of osteogenic differentiation by mesenchymal stem cells. Pharmalogocal induction of canonical Wnt signaling by inhibition of glycogen synthetase kinase , and inhibition of peroxisome-proliferator activated receptor , accelerates osteogenic differentiation by mesenchymal stem cells. These molecules block the action of Dkk-1 and thus may reverse the damage caused by some malignant diseases of the skeleton. There are 4 specific aims. + A1. 'To further validate the utility of Dkk-1 as a blood/tissue marker for malignant and degenerative bone disease in humans. + A2. 'To investigate ex vivo crosstalk between canonical Wnt signaling and the PPAR gamma mediated signaling pathway in human and rodent mesenchymal stem cells from bone marrow stroma in the presence and absence of Dkk-1. + A3. 'To examine the effects of compounds, proteins, and antibodies that have potential to modulate canonical Wnt and PPAR mediated signaling on the levels of adipose and osteoblast progenitors in rodent blood and bone marrow. + A4. 'To examine the potential osteo-inductive effect of such drugs in murine models of malignant bone disease utilizing established cancer lines and tissue derived from osteosarcoma and multiple myeloma patients.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Exploratory Grants (P20)
Project #
5P20RR020152-05
Application #
7720779
Study Section
Special Emphasis Panel (ZRR1-RI-5 (01))
Project Start
2008-08-01
Project End
2009-07-31
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
5
Fiscal Year
2008
Total Cost
$212,752
Indirect Cost
Name
Tulane University
Department
Public Health & Prev Medicine
Type
Schools of Public Health
DUNS #
053785812
City
New Orleans
State
LA
Country
United States
Zip Code
70118
Ade, Catherine M; Derbes, Rebecca S; Wagstaff, Bradley J et al. (2018) Evaluating different DNA binding domains to modulate L1 ORF2p-driven site-specific retrotransposition events in human cells. Gene 642:188-198
Hodel, Karl P; de Borja, Richard; Henninger, Erin E et al. (2018) Explosive mutation accumulation triggered by heterozygous human Pol ? proofreading-deficiency is driven by suppression of mismatch repair. Elife 7:
Liu, Yao-Zhong; Zhang, Lei; Roy-Engel, Astrid M et al. (2017) Carcinogenic effects of oil dispersants: A KEGG pathway-based RNA-seq study of human airway epithelial cells. Gene 602:16-23
Zhang, Q; Liu, S; Parajuli, K R et al. (2017) Interleukin-17 promotes prostate cancer via MMP7-induced epithelial-to-mesenchymal transition. Oncogene 36:687-699
Gopalakrishnan, Anusha M; Aly, Ahmed S I; Aravind, L et al. (2017) Multifunctional Involvement of a C2H2 Zinc Finger Protein (PbZfp) in Malaria Transmission, Histone Modification, and Susceptibility to DNA Damage Response. MBio 8:
Ma, Lin; Li, Jingwu; Nie, Qiang et al. (2017) Organoid culture of human prostate cancer cell lines LNCaP and C4-2B. Am J Clin Exp Urol 5:25-33
Yang, Lingyun; Huang, Feng; Mei, Jiandong et al. (2017) Posttranscriptional Control of PD-L1 Expression by 17?-Estradiol via PI3K/Akt Signaling Pathway in ER?-Positive Cancer Cell Lines. Int J Gynecol Cancer 27:196-205
Zhang, Qiuyang; Liu, Sen; Ge, Dongxia et al. (2017) Targeting Th17-IL-17 Pathway in Prevention of Micro-Invasive Prostate Cancer in a Mouse Model. Prostate 77:888-899
Servant, Geraldine; Streva, Vincent A; Derbes, Rebecca S et al. (2017) The Nucleotide Excision Repair Pathway Limits L1 Retrotransposition. Genetics 205:139-153
Martin, Elizabeth C; Conger, Adrienne K; Yan, Thomas J et al. (2017) MicroRNA-335-5p and -3p synergize to inhibit estrogen receptor alpha expression and promote tamoxifen resistance. FEBS Lett 591:382-392

Showing the most recent 10 out of 157 publications